EUVIMEDEUVIMED entdecken
Crossref

Imaging Features in BMPR2 Mutation–associated Pulmonary Arterial Hypertension

Qinhua Zhao iD, Rui Zhang iD, Jingyun Shi iD, Huikang Xie iD, Liping Zhang iD, Fei Li iD, Rong Jiang, Wenhui Wu, Cijun Luo iD, Hongling Qiu, Huiting Li, Jing He iD und 4 weitere

Radiology · 2023

DOI: 10.1148/radiol.222488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiology, 2023. Verfasst von Qinhua Zhao und 15 weiteren Autor:innen. Beteiligte Einrichtung: From the Departments of Pulmonary Circulation (Q.Z., R.Z., R.J., W.W., C.L., H.Q., H.L., J.H., P.Y., J.L., S.G., L.W.), Radiology (J.S., F.L.), and P…. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Hypertension, Pulmonary. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Pujiang Program, National Natural Science Foundation of Shanghai Scientific and Technological Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Germline mutation in the BMPR2 gene is common in patients with pulmonary arterial hypertension (PAH). However, its association with imaging findings in these patients is, to the knowledge of the authors, unknown.

Purpose

To characterize distinctive pulmonary vascular abnormalities at CT and pulmonary artery angiography in patients with and without BMPR2 mutation. Materials and Methods In this retrospective study, chest CT scans, pulmonary artery angiograms, and genetic test data were acquired for patients diagnosed with idiopathic PAH (IPAH) or heritable PAH (HPAH) between January 2010 and December 2021. Perivascular halo, neovascularity, centrilobular ground-glass opacity (GGO), and panlobular GGO were evaluated at CT and graded on a four-point severity scale by four independent readers. Clinical characteristics and imaging features between patients with BMPR2 mutation and noncarriers were analyzed using the Kendall rank-order coefficient and the Kruskal-Wallis test.

Results

This study included 82 patients with BMPR2 mutation (mean age, 38 years ± 15 [SD]; 34 men; 72 patients with IPAH and 10 patients with HPAH) and 193 patients without the mutation, all with IPAH (mean age, 41 years ± 15; 53 men). A total of 115 patients (42%; 115 of 275) had neovascularity, and 56 patients (20%; 56 of 275) had perivascular halo at CT, and so-called frost crystals were observed on pulmonary artery angiograms in 14 of 53 (26%) patients. Compared with patients without BMPR2 mutation, patients with BMPR2 mutation more frequently showed two distinctive radiographic manifestations, perivascular halo and neovascularity (38% [31 of 82] vs 13% [25 of 193] in perivascular halo [P < .001] and 60% [49 of 82] vs 34% [66 of 193] in neovascularity [P < .001], respectively). "Frost crystals" were more frequent in patients with BMPR2 mutation compared with noncarriers (53% [10 of 19] vs 12% [four of 34]; P < .01). Severe perivascular halo frequently coexisted with severe neovascularity in patients with BMPR2 mutation.

Conclusion

Patients with PAH with BMPR2 mutation showed distinctive features at CT, specifically perivascular halo and neovascularity. This suggested a link between the genetic, pulmonary, and systemic manifestations that underly the pathogenesis of PAH. © RSNA, 2023 Supplemental material is available for this article.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Arterial HypertensionHypertension, PulmonaryMaleHumansAdultRetrospective StudiesMutationBone Morphogenetic Protein Receptors, Type IIHydralazineHydrazones

Substanzen

Bone Morphogenetic Protein Receptors, Type IIhydralazine 4-anisaldehyde hydrazoneHydralazineHydrazonesBMPR2 protein, human

Autor:innen und Institutionen

  • From the Departments of Pulmonary Circulation (Q.Z., R.Z., R.J., W.W., C.L., H.Q., H.L., J.H., P.Y., J.L., S.G., L.W.), Radiology (J.S., F.L.), and Pathology (H.X., L.Z.), Shanghai Pulmonary Hospital, Tongji University…

ORCID-Profile: Qinhua Zhao, Rui Zhang, Jingyun Shi, Huikang Xie, Liping Zhang, Fei Li, Cijun Luo, Jing He, Sugang Gong, Lan Wang

Förderung

  • National Natural Science Foundation of China
  • Shanghai Pujiang Program
  • National Natural Science Foundation of Shanghai Scientific and Technological Committee

Zitieren

APA

Zhao, Q., Zhang, R., Shi, J., Xie, H., Zhang, L., Li, F., Jiang, R., Wu, W., Luo, C., Qiu, H., Li, H., He, J., Yuan, P., Liu, J., Gong, S., & Wang, L. (2023). Imaging Features in BMPR2 Mutation–associated Pulmonary Arterial Hypertension. Radiology. https://doi.org/10.1148/radiol.222488

Vancouver

Zhao Q, Zhang R, Shi J, Xie H, Zhang L, Li F, et al. Imaging Features in BMPR2 Mutation–associated Pulmonary Arterial Hypertension. Radiology. 2023. doi:10.1148/radiol.222488

BibTeX
@article{Zhao2023,
  author = {Zhao, Qinhua and Zhang, Rui and Shi, Jingyun and Xie, Huikang and Zhang, Liping and Li, Fei and Jiang, Rong and Wu, Wenhui and Luo, Cijun and Qiu, Hongling and Li, Huiting and He, Jing and Yuan, Ping and Liu, JinMing and Gong, Sugang and Wang, Lan},
  title = {Imaging Features in BMPR2 Mutation–associated Pulmonary Arterial Hypertension},
  journal = {Radiology},
  year = {2023},
  doi = {10.1148/radiol.222488}
}
Kostenlos starten →